Furthermore, NLRP3 up-regulation in C1498 led to a statistically shorter survival than Ctrl-GFP AML mice [median 22 (range 21-24) days vs median 27 (range 25-28) days (P=0.0188)] (Figure 2E). The gene discussed is NLRP3; the disease is acute myeloid leukemia.